Rheumatoid arthritis: a new challenge in coming era.
Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Rewatkar
Prarthana V
PV
Department of Pharmaceutical Chemistry, Srimati Kashibai Navale College of Pharmacy, Kondhwa, Pune, India. prarthanapcp@rediffmail.com
Kokil
Ganesh R
GR
Verma
Arunima
A
Thareja
Suresh
S
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000700:Analgesics / Q000737:chemistry / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000737:chemistry / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000737:chemistry / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D052246:Cyclooxygenase 2 Inhibitors / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D014150:Antipsychotic Agents; D018501:Antirheumatic Agents; D052246:Cyclooxygenase 2 Inhibitors